Tag: coronary stents industry

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The coronary stents market has seen significant growth in recent years, driven by various medical and technological advancements. This sector is expected to continue expanding steadily, supported by rising cardiovascular health concerns and innovations in stent design and materials. Let’s delve into the market’s current size, growth drivers, segmentation, strategic developments, key players, and regional prospects.

Overview of Coronary Stents Market Size and Expected Growth

The coronary stents market has experienced robust growth, increasing from $11.9 billion in 2025 to an anticipated $12.9 billion in 2026. This represents a compound annual growth rate (CAGR) of 8.3%. This positive trend reflects factors such as the growing incidence of coronary artery disease, a rise in percutaneous coronary intervention procedures, improved stent coating technologies, wider availability of interventional cardiology services, and better clinical outcomes associated with coronary stenting.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Future Projections for Coronary Stents Market Expansion

Looking ahead, the coronary stents market is projected to expand further, reaching $17.76 billion by 2030, maintaining a steady CAGR of 8.3%. This anticipated growth stems from an aging population with increased cardiovascular risks, rising demand for minimally invasive cardiac treatments, broader adoption of next-generation stent technologies, greater attention to long-term vessel healing and patient outcomes, and enhanced access to cardiac care, especially in emerging markets. Key trends expected to influence the market include the growing use of drug-eluting and dual therapy stents, preference for minimally invasive procedures, efforts to reduce restenosis and thrombosis, increased utilization of bioresorbable and biodegradable stents, and a rising demand for advanced stent materials and designs.

Primary Factors Driving Growth in the Coronary Stents Market

One of the main factors propelling the coronary stents market is the escalating prevalence of cardiovascular diseases (CVDs). These disorders, involving the heart and blood vessels, include coronary artery disease, heart failure, stroke, and hypertension. The rise in CVD cases is linked to aging populations and an increase in risk factors such as obesity, diabetes, sedentary lifestyles, unhealthy diets, and stress. Coronary stents are essential in treating these conditions by reopening narrowed or blocked arteries, thus improving blood flow to the heart and lowering the risk of heart attacks.

Access The Complete Coronary Stents Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Healthcare Data Reinforces Market Growth Drivers

For example, in October 2024, the US Centers for Disease Control and Prevention reported that cardiovascular disease caused 919,032 deaths in 2023, accounting for about one in every three deaths nationally. This alarming statistic highlights the critical need for coronary stents, reinforcing their growing demand as a vital treatment option and pushing the market forward.

Detailed Breakdown of Coronary Stents Market Segmentation

This report segments the coronary stents market by various categories:

– Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

– Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, and other technologies

– Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

– Deployment Method: Self-Expandable Stents, Balloon-Expandable Stents

– End Use: Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Other End Uses

The product types are further divided into subcategories such as sirolimus-, paclitaxel-, and everolimus-eluting dual therapy stents; beta and gamma radiation radioactive stents; manual, mechanical, and hydrodynamic thrombectomy stents; various covered stents including PTFE and ePTFE; bioresorbable stents based on polymer, metal, and ceramic; biodegradable stents like polymeric and magnesium-based; hybrid drug-eluting and biodegradable or metal stents; and drug-eluting stents differentiated by their drug types, as well as several types of bare metal stents.

Innovative Trends Defining the Coronary Stents Market’s Future

Leading companies in the market are focusing on developing advanced products, especially drug-eluting stents, which help minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents work by slowly releasing medication to prevent artery re-narrowing. For instance, in May 2024, Abbott, a US healthcare firm, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features enhanced design elements, a novel delivery system, and specialized sizing options to tackle complex cases. It retains the drug-eluting coating that reduces artery re-blockage risk and is supported by an outstanding safety record from over 120 clinical trials involving more than 120,000 patients.

Key Players Shaping the Coronary Stents Market Landscape

The coronary stents market includes a range of prominent companies such as Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, and Minvasys.

Regional Outlook Highlights for the Coronary Stents Market

In 2025, North America was the largest regional market for coronary stents. However, the Asia-Pacific region is expected to emerge as the fastest-growing market during the forecast period. This analysis spans key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a thorough global perspective on market opportunities and trends.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Coronary Stents Market Expected To Change From 2026 To 2030?

The coronary stents market has experienced substantial expansion in recent years. This market is projected to expand from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by factors such as the increasing incidence of coronary artery disease, a rise in percutaneous coronary intervention procedures, innovations in stent coating technologies, the broadening of interventional cardiology services, and better clinical results from coronary stenting.

The coronary stents market is anticipated to experience substantial expansion over the coming years. Projections indicate it will reach $17.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.3%. This projected growth is driven by factors such as an aging demographic prone to increased cardiovascular risk, a surging demand for less invasive cardiac procedures, the wider integration of advanced stent technologies, an elevated emphasis on sustained vessel recovery and patient results, and improved availability of cardiac interventions in developing regions. Key trends anticipated during this period encompass the increased use of drug-eluting and dual therapy stents, a growing inclination towards minimally invasive coronary procedures, a heightened commitment to mitigating risks of restenosis and thrombosis, the expanding application of bioresorbable and biodegradable stents, and an escalating need for innovative stent materials and designs.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Key Drivers Are Affecting The Coronary Stents Market Development?

The increasing prevalence of cardiovascular diseases (CVDs) is anticipated to propel the growth of the coronary stent market going forward. These conditions, known as cardiovascular diseases, encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population and an increased occurrence of risk factors like obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is essential for individuals with cardiovascular diseases to open narrowed or blocked coronary arteries, thereby improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. Therefore, the escalating prevalence of cardiovascular diseases (CVDs) is driving the expansion of the coronary stent market.

Which Segments Define The Coronary Stents Market Segment Structure?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Trends Are Transforming The Coronary Stents Market?

Major companies operating in the coronary stent market are developing innovative products, such as drug-eluting stents, with the goal of reducing the necessity for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents featuring a medication coating designed to prevent the re-narrowing of arteries by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its enhanced design, a new delivery system, and unique size options, specifically engineered to handle challenging medical cases. It retains the specialized coating that helps reduce the risk of artery re-blockage, consistent with other XIENCE stents. This particular stent benefits from an exceptional safety record, supported by over 120 clinical trials involving more than 120,000 patients.

Who Are The Established Players Within The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

Get The Full Coronary Stents Market Report:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Which Region Leads The Coronary Stents Market In Terms Of Market Share?

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Coronary Stents Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company

Atherectomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

Coronary Angiography Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Coronary Stents Market By 2030 Starting From Its 2026 Size?

The coronary stents market has seen substantial expansion over recent years. It is projected to increase from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. The growth witnessed historically can be linked to the increasing incidence of coronary artery disease, a rising number of percutaneous coronary intervention procedures, advancements in stent coating technologies, the expansion of interventional cardiology services, and improved clinical outcomes associated with coronary stenting.

The coronary stents market size is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $17.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.3%. This projected expansion during the forecast period stems from factors such as an aging demographic prone to increased cardiovascular risks, a rising need for less invasive cardiac interventions, the wider embrace of advanced stent technologies, a heightened emphasis on durable vessel healing and improved patient results, and broader availability of cardiac care in developing regions. Key developments expected during this period involve a greater uptake of drug-eluting and dual therapy stents, a stronger inclination towards minimally invasive coronary procedures, an intensified drive to mitigate restenosis and thrombosis hazards, the broader utilization of bioresorbable and biodegradable stents, and an escalating requirement for innovative stent materials and designs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Market Drivers Are Supporting The Expansion Of The Coronary Stents Market?

The growing occurrence of cardiovascular diseases (CVDs) is anticipated to fuel the expansion of the coronary stent market going forward. These diseases encompass various heart and blood vessel conditions, such as coronary artery disease, heart failure, stroke, and high blood pressure. The increase in CVDs is linked to an aging global population and a higher incidence of risk factors including obesity, diabetes, inactive routines, unhealthy eating habits, and stress. Coronary stents become necessary in such cases to unblock or widen constricted coronary arteries, thereby enhancing blood circulation to the heart and lowering the likelihood of heart attacks. For example, data from October 2024, provided by the US government agency, the Centers for Disease Control and Prevention, revealed that in 2023, cardiovascular disease was responsible for 919,032 fatalities, representing approximately one in every three deaths. Consequently, the escalating incidence of cardiovascular diseases (CVDs) is significantly contributing to the growth of the coronary stent market.

Which Segment Categories Define The Coronary Stents Market?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Major Market Trends Are Driving Changes In The Coronary Stents Market?

Leading companies in the coronary stent market are introducing advanced products, such as drug-eluting stents, aimed at decreasing the necessity for recurrent interventions when contrasted with bare-metal stents. These drug-eluting stents are specialized devices for coronary arteries, featuring a medicinal coating that steadily releases drugs to prevent the arteries from narrowing again. For instance, in May 2024, Abbott, a US-based healthcare company, rolled out the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its improved design, a novel delivery system, and distinct size options, specifically engineered to manage complex cases. It maintains the specialized coating that diminishes the risk of artery re-blockage, consistent with other XIENCE stents. This particular stent boasts an outstanding safety profile, substantiated by more than 120 clinical trials involving over 120,000 patients.

Who Are The Top Companies Competing In The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

Read the full coronary stents market report here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

How Is The Coronary Stents Market Distributed Across Key Geographic Regions?

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Coronary Stents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company

Atherectomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

Coronary Angiography Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Coronary Stents Market?

The coronary stents market size has experienced strong growth in recent years. It is projected to expand from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. This historical growth can be attributed to a rising prevalence of coronary artery disease, an increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, the expansion of interventional cardiology services, and improved clinical outcomes from coronary stenting.

The coronary stents market is projected to experience robust expansion in the upcoming years, with its value anticipated to reach $17.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period can be attributed to several factors, including an aging demographic with elevated cardiovascular risks, a rising demand for less invasive cardiac procedures, the increasing integration of advanced stent technologies, a greater emphasis on sustained vessel recovery and improved patient results, and the broadening availability of cardiac care in developing regions. Key trends expected during this period involve the heightened adoption of drug-eluting and dual therapy stents, a growing preference for less invasive coronary interventions, increased efforts to mitigate the risks of restenosis and thrombosis, the wider application of bioresorbable and biodegradable stents, and a surging demand for innovative stent materials and designs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Drivers Are Supporting The Rise Of The Coronary Stents Market?

The increasing occurrence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market in the future. CVDs encompass various disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population and a higher prevalence of risk factors, including obesity, diabetes, sedentary lifestyles, poor diet, and stress. A coronary stent is essential for cardiovascular diseases to open narrowed or blocked coronary arteries, thereby improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths. Consequently, the growing prevalence of cardiovascular diseases (CVDs) is propelling the growth of the coronary stent market.

What Segments Are Identified Within The Structure Of The Coronary Stents Market?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Trends Are Reshaping The Dynamics Of The Coronary Stents Market?

Major companies in the coronary stent market are developing innovative products, such as drug-eluting stents, to reduce the frequency of repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents featuring a medication coating designed to prevent arteries from re-narrowing by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is notable for its enhanced design, new delivery system, and unique size options, specifically engineered to manage challenging cases. It retains the specialized coating that minimizes the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, evidenced by over 120 clinical trials involving more than 120,000 patients.

Which Key Market Players Are Investing In Expansion And Innovation Within The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Which Regions Are Poised For Strategic Growth In The Coronary Stents Market?

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Coronary Stents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company

Atherectomy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report

Coronary Angiography Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the coronary stents market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Coronary Stents Market Size?

The market for coronary stents has experienced strong expansion in recent years. Its value is projected to escalate from $11.06 billion in 2024 to $11.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be ascribed to a rising preference for minimally invasive procedures, broader healthcare availability in emerging markets, increased healthcare spending, an uptick in percutaneous coronary interventions, and a growing count of cardiologists.

The coronary stents market is poised for considerable expansion in the coming years. It is projected to achieve a size of $16.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.3%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing occurrence of cardiovascular diseases, an aging global demographic, greater public awareness regarding cardiovascular health, supportive government initiatives and funding, and the rising prevalence of lifestyle-related conditions. Noteworthy trends expected over the forecast period include continuous innovations in stent technology, advancements in imaging technologies, the establishment of strategic collaborations and partnerships, new developments in stent materials, and the integration of technology with digital health.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What Core Market Drivers Are Expanding The Coronary Stents Industry?

The increasing occurrence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market in the future. These diseases encompass various conditions affecting the heart and blood vessels, such as coronary artery disease, heart failure, stroke, and hypertension. Their rise can be attributed to an aging global populace and a higher incidence of risk factors like obesity, diabetes, inactive lifestyles, unhealthy dietary habits, and stress. A coronary stent becomes necessary in such cases to widen constricted or obstructed coronary arteries, thereby enhancing blood circulation to the heart and lowering the likelihood of heart attacks. For example, in August 2022, a report from the American College of Cardiology, a US-based non-profit medical association, forecasted substantial increases in cardiovascular risk factors across the U.S. between 2025 and 2060. Diabetes is predicted to increase by 39.3% to 55 million people, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The most substantial increases in actual cardiovascular diseases are projected for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). Consequently, the growing incidence of cardiovascular diseases (CVDs) is fueling the expansion of the coronary stent market.

What Segment Insights Are Highlighted In The Coronary Stents Market Report?

The coronary stentsmarket covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Which Notable Trends Are Transforming The Coronary Stents Market Outlook?

Leading companies in the coronary stent market are developing innovative products, such as drug-eluting stents, with the aim of reducing the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents that are coated with medication, designed to prevent the re-narrowing of arteries by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its enhanced design, new delivery system, and unique size options, all specifically engineered to manage challenging cases. It continues to feature the specialized coating that minimizes the risk of artery re-blockage, consistent with other XIENCE stents. This stent boasts an exceptional safety record, evidenced by over 120 clinical trials involving more than 120,000 patients.

Which Firms Are Driving Innovation Within The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Regional Trends Are Shaping Growth In The Coronary Stents Market?

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2025, By The Business Research Company

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Disposable Endoscopes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disposable-endoscopes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Coronary Stents Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The valuation of the coronary stents market has experienced significant upward momentum recently, projected to increase from $11.06 billion in the year 2024 to $11.9 billion by 2025, reflecting a compound annual growth rate of 7.6%.This expansion during the past period stems from several factors, including an increasing inclination toward less invasive medical interventions, broadening availability of medical services in developing economies, escalating spending on healthcare, a higher volume of percutaneous coronary procedures being performed, and a larger pool of practicing cardiologists.

Anticipating robust expansion over the ensuing years, the market for coronary stents is projected to reach a valuation of $16.4 billion by 2029, propelled by an 8.3% compound annual growth rate (CAGR); this upward trajectory is fundamentally fueled by the escalating prevalence of heart-related ailments, an expanding elderly demographic, heightened public consciousness regarding cardiac wellness, favorable governmental initiatives and financial backing, alongside the climbing rates of diseases linked to modern lifestyles, while key developments shaping this period encompass advancements in stent design, improvements in visualization techniques, strategic alliances and cooperative agreements, novelties in stent fabrication substances, and the incorporation of digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

Which Factors And Drivers Are Influencing The Coronary Stents Market In 2025?

The expanding incidence of cardiovascular ailments (CVDs) is anticipated to fuel the expansion of the coronary stent market moving ahead.These disorders affecting the heart and blood vessels encompass various conditions such as stroke, heart failure, coronary artery disease, and elevated blood pressure.Their escalation is attributable to demographic shifts toward an older population, coupled with the greater frequency of risk elements like sedentary habits, inadequate nutrition, strain, diabetes, and excessive weight.To address these cardiovascular issues, a coronary stent becomes necessary to restore patency in constricted or obstructed coronary arteries, thereby enhancing cardiac circulation and mitigating the danger of myocardial infarction.As an illustration, data released in August 2022 by the American College of Cardiology, a US-based organization focused on medical non-profit endeavors, forecasted substantial upticks in cardiovascular risk factors within the United States between 2025 and 2060; specifically, diabetes cases are projected to climb by 39.3% reaching 55 million individuals, dyslipidemia by 27.6% amounting to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% also to 126 million.The most pronounced growth in CVD cases is foreseen for stroke, showing a 33.8% jump to 15 million, and heart failure, increasing by 33.4% to 13 million, with ischemic heart disease projected to rise by 30.7% to 29 million, and heart attacks by 16.9% to 16 million following closely.Consequently, this growing burden of cardiovascular diseases (CVDs) serves as a key impetus for the advancement of the coronary stent sector.

What Are The Different Segment Classifications Within The Coronary Stents Market?

The coronary stentsmarket covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Which Market Trends Are Creating New Opportunities In The Coronary Stents Industry?

Leading corporations within the coronary stent sector are focused on creating cutting-edge solutions, including drug-eluting stents, aiming to minimize the necessity for subsequent interventions when contrasted with traditional bare-metal versions.These sophisticated devices feature a medicinal coating engineered to gradually release pharmaceuticals, thereby inhibiting the restenosis process in arteries.A notable example occurred in May of 2024 when Abbott, an American multinational medical device firm, introduced its XIENCE Sierra Everolimus Eluting Coronary Stent System into the Indian market.This specific XIENCE Sierra stent is distinct due to its improved architecture, a novel deployment mechanism, and a selection of sizes tailored for intricate clinical scenarios, all while preserving the distinctive coating that mitigates the danger of vessel re-occlusion, mirroring attributes of preceding XIENCE models.Furthermore, this device boasts an impressive history of patient safety, substantiated by evidence from upwards of 120 comprehensive clinical studies encompassing more than 120,000 participants.

Which Key Players Are Driving Competition In The Coronary Stents Market?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Are The Key Regional Factors Influencing The Coronary Stents Market Growth?

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Coronary Stents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Browse Through More Reports Similar to the Global Coronary Stents Market 2025, By The Business Research Company

Bioabsorbable Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Intracranial Stents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

Disposable Endoscopes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disposable-endoscopes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Coronary Stents Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In the previous years, there has been significant growth in the coronary stents market size. It is predicted to increase from $11.06 billion in 2024 to $11.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.6%. The expansion during the historic era can be credited to the escalating preference for minimally invasive methods, growth of healthcare accessibility in emerging markets, increase in healthcare spending, rise in percutaneous coronary interventions, and a growing population of cardiologists.

It is predicted that the coronary stents market will experience substantial expansion in coming years, with projections for it to reach $16.4 billion by 2029 with a compound annual growth rate (CAGR) of 8.3%. This upswing during the forecast period is mainly due to an increase in cardiovascular diseases, an ageing populace, heightened awareness surrounding heart health, government backing and funding, and rising incidence of lifestyle-related diseases. The forecast period also signifies important trends such as advancements in stent and imaging technology, strategic alliances and partnerships, novel developments in stent materials, and technological mergers with digital health.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Coronary Stents Market?

The coronary stent market is predicted to expand due to the escalating occurrence of cardiovascular diseases (CVDs). Heart and blood vessel-related disorders such as coronary artery disease, hypertension, heart failure, and stroke fall under the spectrum of cardiovascular diseases. The increase in such diseases is primarily due to factors like an aged population, obesity, diabetes, lack of physical activity, unhealthy diet, and stress. To alleviate cardiovascular diseases, coronary stents are employed to widen or unclog coronary arteries, thus improving heart blood flow and decreasing heart attack risk. For example, according to a report by the American College of Cardiology, a U.S. non-profit medical association, in August 2022, a significant escalation in cardiovascular risk factors is projected between 2025 and 2060 in the U.S. Diabetes is projected to increase by 39.3%, affecting 55 million people, with dyslipidemia increasing by 27.6% to 126 million, hypertension growing by 25.1% to 162 million, and obesity increasing by 18.3% to 126 million. Stroke and heart failure are expected to witness the most substantial escalations among cardiovascular diseases, rising by 33.8% and 33.4% respectively. This is followed by ischemic heart disease rising by 30.7% and heart attacks increasing by 16.9%. Consequently, the accelerating occurrence of cardiovascular diseases (CVDs) is fueling the growth of the coronary stent market.

Which Key Market Segments Comprise the Coronary Stents Market and Drive Its Revenue Growth?

The coronary stentsmarket covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Which Areas Are Leading Regions in the Coronary Stents Market Expansion Across the Globe?

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theCoronary Stents Market Direction?

Significant players in the coronary stent sector, such as Abbott, are working on breakthrough products that could reduce the requirement for additional procedures in comparison to traditional bare-metal stents. For instance, they’re creating drug-eluting stents, a type of coronary stent coated with medical substances designed to slow down the process of arteries narrowing. They do so by gradually releasing drugs over a specified period. Notably, in May 2024, US-based healthcare firm Abbott unveiled its XIENCE Sierra Everolimus Eluting Coronary Stent System in India, setting it apart with its superior design, innovative delivery system, and unique sizing options, devised for particularly difficult cases. Like all other XIENCE stents, it has a particular coating designed to mitigate the risk of arteries blocking again. Over 120 clinical trials involving above 120,000 patients, confirming its remarkable safety profile, back this stent.

View the full report here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

How Is the Coronary Stents Market Conceptually Defined?

Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Coronary Stents Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the coronary stents market has expanded significantly over the past few years. The market is projected to increase from a worth of $11.06 billion in 2024 to $12.02 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.6%. The historical development of the market can be credited to the growing inclination towards less invasive procedures, spreading healthcare accessibility in upcoming markets, escalating healthcare spending, a rise in percutaneous coronary interventions and an expanding count of cardiologists.

What Is the Forecast for the Coronary Stents Market Size Through 2029?

The market size of coronary stents is anticipated to experience robust growth in the coming years, expanding to $16.5 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.3%. This growth projection for the forecast period can be ascribed to the growing prevalence of heart diseases, the aging demographic, heightened awareness of heart health, government support and funding, as well as a surge in lifestyle diseases. Key trends for this forecast period encompass advances in stent and imaging technologies, strategic collaborations and partnerships, innovative stent materials and the integration of digital health with technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What are the Key Market Players in Coronary Stents Market and How They’re Evolving?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

What Are the Primary Growth Drivers in the Coronary Stents Market?

The escalating occurrence of cardiovascular diseases (CVDs) is predicted to drive the expansion of the coronary stent market in the future. Cardiovascular diseases, which encompass disorders of the heart and blood vessels such as coronary artery disease, heart failure, stroke, and hypertension, are on the rise. Factors contributing to this growth include an ageing population, obesity, diabetes, inactive lifestyles, poor nutrition, and stress levels. A coronary stent, which aids in opening narrowed or blocked coronary arteries, thereby enhancing blood flow to the heart and diminishing the chance of heart attacks, is a crucial treatment for these diseases. For example, a study by the American College of Cardiology, a US-based non-profit medical association, forecasted in August 2022 a substantial uptick in cardiovascular risk factors in the US from 2025 to 2060. The number of diabetes cases is expected to grow by 39.3% to 55 million, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The largest expected increases in cardiovascular diseases are for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million). These are closely followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). As such, the growing occurrence of cardiovascular diseases (CVDs) fuels the expansion of the coronary stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

What Are the Leading Segments in the Global Coronary Stents Industry?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Are the Key Market Trends in the Coronary Stents Industry?

Leading enterprises in the coronary stent market are pioneering novel products like drug-eluting stents to decrease the necessity for subsequent procedures in comparison to bare-metal stents. Drug-eluting stents are special coronary stents layered with medications that help prevent artery re-narrowing by slowly discharging drugs over a certain period. An example is Abbott, an American health firm, who introduced the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India in May 2024. The XIENCE Sierra stent is distinctive due to its improved design, innovative delivery system, and exclusive size choices. It’s specifically built to tackle difficult cases while maintaining the custom coating that curtails the likelihood of artery re-obstruction, just like other XIENCE stents. Over 120 clinical trials involving more than 120,000 individuals back this stent’s superb safety history.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Is the Regional Outlook for the Coronary Stents Market?

North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

This Report Delivers Insight On:

1. How big is the coronary stents market, and how is it changing globally?

2. Who are the major companies in the coronary stents market, and how are they performing?

3. What are the key opportunities and risks in the coronary stents market right now?

4. Which products or customer segments are growing the most in the coronary stents market?

5. What factors are helping or slowing down the growth of the coronary stents market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the coronary stents industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Coronary Stents Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

In recent times, the coronary stents market has experienced robust growth. The market is projected to expand from $11.06 billion in 2024 to $12.02 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%. The historical growth trend can be traced back to various factors such as a growing inclination towards minimally invasive procedures, accessibility to healthcare in upcoming markets, increased healthcare spending, upward trend in percutaneous coronary interventions, and an increase in the cohort of cardiologists._x000D_

_x000D_

The market size for coronary stents is projected to witness significant expansion in the forthcoming years. The market’s value is predicted to rise to $16.5 billion by the year 2029, having a compound annual growth rate (CAGR) of 8.3%. This projected growth during the forecast period can be linked to several factors including an upsurge in cardiovascular diseases, an ageing population, increased cognizance about heart health, supportive governmental schemes and funding, along with an increase in lifestyle-related diseases. Key trends expected during this forecast period encompass advancements in stent technology, breakthroughs in imaging technologies, strategic alliances and partnerships, and developments in stent materials and technological integration with digital health._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Coronary Stents Market?#_x000D_

The hike in the cases of cardiovascular diseases (CVDs) is foreseen to boost the development of the coronary stent market. CVDs encompass a bunch of disorders associated with the heart and blood vessels, inclusive of conditions such as coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases can be linked to factors like an aging population, an upsurge in risk factors such as obesity, diabetes, lack of exercise, poor nutrition, and increased stress levels. A coronary stent is vital for treating cardiovascular diseases as it aids in opening up narrowed or blocked coronary arteries, enhancing blood circulation to the heart, and minimizing the risk of heart attacks. For instance, a report by the American College of Cardiology in August 2022, a non-profit medical organization based in the U.S., forecasted a sizable increase in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicts diabetes to escalate by 39.3% to 55 million people, dyslipidemia to surge by 27.6% to 126 million, hypertension to go up by 25.1% to 162 million, and obesity to increase by 18.3% to 126 million. The largest increase is projected for stroke (33.8% increase to 15 million) and heart failure (33.4% hike to 13 million), followed by ischemic heart disease (30.7% rise to 29 million) and heart attacks (16.9% boost to 16 million). Hence, the escalating cases of cardiovascular diseases (CVDs) are propelling the expansion of the coronary stent market._x000D_

_x000D_

#Which Key Market Segments Comprise the Coronary Stents Market and Drive Its Revenue Growth?#_x000D_

The coronary stents market covered in this report is segmented –_x000D_

_x000D_

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents_x000D_

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies_x000D_

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer_x000D_

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents_x000D_

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents_x000D_

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents_x000D_

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents_x000D_

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents_x000D_

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents_x000D_

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents_x000D_

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents_x000D_

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents_x000D_

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents_x000D_

_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Coronary Stents Market Expansion Across the Globe?#_x000D_

North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Strategic Trends Steering theCoronary Stents Market Direction?#_x000D_

Leading corporations in the coronary stent market are focusing on the innovation of products like drug-eluting stents, to decrease the necessity for repeated procedures, a common issue with bare-metal stents. Drug-eluting stents are exclusive coronary stents that are covered with medicine which aids in avoiding the arteries’ re-narrowing by slowly releasing the drugs over a period. For instance, Abbott, an American healthcare firm, in May 2024, introduced the XIENCE Sierra Everolimus (a drug) Eluting Coronary Stent System in India. What makes the XIENCE Sierra stent unique is its refined design, new mode of delivery, and its exclusive size range, all tailored to handle complex cases. It maintains the special coating that helps to minimize the chance of re-blockage of arteries, which is a shared feature among all XIENCE stents. This particular stent holds a noteworthy safety record, and it is supported by more than 120 clinical trials which involve over 120,000 patients._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report_x000D_

_x000D_

#How Is the Coronary Stents Market Conceptually Defined?#_x000D_

Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theCoronary Stents Market?

The growth of the coronary stent market is anticipated to be fueled by the increasing incidence of cardiovascular diseases (CVDs). These diseases include disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, high blood pressure, and stroke. The surge in cardiovascular diseases can be attributed to several factors, like an aging population, increased incidences of obesity, diabetes, inactive lifestyles, poor diet, and stress. To treat these diseases, a coronary stent is utilized to unblock or widen coronary arteries, enhancing the heart’s blood supply and lowering heart attack risk. For example, the American College of Cardiology, a non-profit medical organization based in the US, predicted substantial growth in cardiovascular risk factors in the U.S from 2025 to 2060, in a report published in August 2022. They anticipated that diabetes would increase by 39.3% affecting 55 million people, dyslipidemia by 27.6% impacting 126 million, hypertension by 25.1% reaching 162 million, and obesity by 18.3% affecting 126 million. The most considerable growth in cardiovascular diseases is expected to be in strokes (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), succeeded by ischemic heart disease (30.7% rise to 29 million) and heart attacks (16.9% rise to 16 million). Thus, the surge in cardiovascular diseases (CVDs) is propelling the growth of the coronary stent market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

#What Long-Term Growth Rate is Expected for theCoronary Stents Market Between 2025 and 2034?

The expansion of the coronary stents market has been robust in recent years. An increase from $11.06 billion in 2024 to $12.02 billion in 2025, with a compound annual growth rate (CAGR) of 8.6% is projected. This growth during the historical period can be associated with a trend towards minimally invasive procedures, increased access to healthcare in developing markets, higher healthcare spending, a rise in percutaneous coronary interventions, and a growing number of cardiologists.

The market for coronary stents is predicted to experience robust growth in the near future, with projections suggesting it will balloon to $16.5 billion by 2029, showing a compound annual growth rate (CAGR) of 8.3%. This anticipated expansion during the forecast period can be credited to a rising prevalence of cardiovascular ailments, an aging populace, increasing consciousness about heart health, beneficial governmental initiatives and funding, and a surge in lifestyle diseases. The forecast period might witness significant trends such as advancements in stent technology, breakthroughs in imaging technologies, strategic alliances and partnerships, innovations in the materials used for stents and technological incorporation with digital health.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theCoronary Stents Market?

In the coronary stent market, leading businesses like Abbott are creating ground-breaking products such as drug-eluting stents to minimize the requirement for multiple procedures in contrast to bare-metal stents. The drug-eluting stents are highly specialized, covered with a medication designed to avert arteries from re-narrowing by slowly dispensing medicines over a period. For instance, in May 2024, Abbott, a renowned healthcare enterprise from the USA, introduced its XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The distinctive features of the XIENCE Sierra stent include its improved design, novel delivery system, and unique size options, all designed to deal with difficult cases. The stent continues to have the characteristic coating that lowers the chances of artery re-narrowing, mirroring the standard set by previously released XIENCE stents. This stent boasts an exceptional safety track record, substantiated by over 120 clinical trials that involved more than 120,000 patients.

Who Are the Key Market Players Influencing the Growth of the Corn and Coronary Stents Industry?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Which Key Market Segments Comprise the Coronary Stents Market and Drive Its Revenue Growth?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

Which Regions Are Emerging as Leaders in the Coronary Stents Market?

North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Coronary Stents Market 2025, By The Business Research Company:

Bioabsorbable Stents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Disposable Endoscopes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/disposable-endoscopes-global-market-report

High-Resolution Anoscopy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/high-resolution-anoscopy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: